Photochemotherapy induces a faster apoptosis of alloreactive activated T cells than of nonalloreactive resting T cells in graft versus host disease

Transplantation

Volumn 90, Issue 11, 2010, Pages 1232-1238

  Hannani, Dalil ^a,b,c   Merlin, Etienne ^d   Gabert, Françoise ^a,b,c   Laurin, David ^a,b,c   Deméocq, François ^d,e   Chaperot, Laurence ^a,b,c   Kanold, Justyna ^d,e   Plumas, Joel ^a,b,c  

^a INSERM   (France)

^b UNIV GRENOBLE ALPES   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d HÔTEL DIEU   (France)

^e UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Apoptosis; Extracorporeal photochemotherapy; GvHD; T lymphocyte

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; PSORALEN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DONOR; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; KINETICS; MITOGENICITY; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ULTRAVIOLET A RADIATION;

APOPTOSIS; CHRONIC DISEASE; CYTOKINES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFUSION; PHOTOPHERESIS; T-LYMPHOCYTES;

EID: 78650368194     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181fa4eb6     Document Type: Article

References (30)

1. Paczesny S, Hanauer D, Sun Y, et al. New perspectives on the biology of acute GVHD. Bone Marrow Transplant 2010; 45: 1.
2. Ferrara JL, Levine JE, Reddy P, et al. Graft-versus-host disease. Lancet 2009; 373: 1550.
3. Sakoda Y, Hashimoto D, Asakura S, et al. Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. Blood 2007; 109: 1756.
4. + T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease. J Immunol 2007; 179: 3305.
5. Martin PJ. Biology of chronic graft-versus-host disease: Implications for a future therapeutic approach. Keio J Med 2008; 57: 177.
6. Laurin D, Hannani D, Pernollet M, et al. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft. Transfusion 2010; 50: 418.
7. Greinix HT, Knobler RM, Worel N, et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica 2006; 91: 405.
8. Rubegni P, Cuccia A, Sbano P, et al. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease. Br J Haematol 2005; 130: 271.
9. Foss FM, DiVenuti GM, Chin K, et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: Analysis of response and survival in-corporating prognostic factors. Bone Marrow Transplant 2005; 35: 1187.
10. Couriel DR, Hosing C, Saliba R, et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006; 107: 3074.
11. Flowers ME, Apperley JF, van Besien K, et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood2008; 112: 2667.
12. Suchin KR, Cassin M, Washko R, et al. Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens. J Am Acad Dermatol 1999; 41: 980.
13. Plumas J, Manches O, Chaperot L. Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD: Involvement of dendritic cells. Leukemia 2003; 17: 2061.
14. Enomoto DN, Schellekens PT, Yong SL, et al. Extracorporeal photochemotherapy (photopheresis) induces apoptosis in lymphocytes: A possible mechanism of action of PUVA therapy. Photochem Photobiol 1997; 65: 177.
15. Hannani D, Gabert F, Laurin D, et al. Photochemotherapy induces the apoptosis of monocytes without impairing their function. Transplantation 2010; 89: 492.
16. French LE, Alcindor T, Shapiro M, et al. Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: Positive correlation with response to photopheresis. Bone Marrow Transplant 2002; 30: 509.
17. French LE, Lessin SR, Addya K, et al. Identification of clonal T cells in the blood of patients with systemic sclerosis: Positive correlation with response to photopheresis. Arch Dermatol 2001; 137: 1309.
18. French LE, Rook AH. T cell clonality and the effect of photopheresis in systemic sclerosis and graft versus host disease. Transfus Apher Sci 2002; 26: 191.
19. Toubai T, Sun Y, Reddy P. GVHD pathophysiology: Is acute different from chronic? Best PractRes Clin Haematol 2008; 21: 101.
20. Reddy P, Ferrara JL. Immunobiology of acute graft-versus-host disease. Blood Rev 2003; 17: 187.
21. Ma A, KokaR, Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 2006; 24: 657.
22. Tsutsumi Y, Tanaka J, Miura Y, et al. Molecular analysis of T-cell repertoire in patients with graft-versus-host disease after allogeneic stem cell transplantation. Leuk Lymphoma 2004; 45: 481.
23. O'Keefe CL, Risitano AM, Maciejewski JP. Clinical implications of T cell receptor repertoire analysis after allogeneic stem cell transplantation. Hematology 2004; 9: 189.
24. Aspord C, Charles J, Leccia MT, et al. A novel cancer vaccine strategy based on HLA-A*0201 matched allogeneic plasmacytoid dendritic cells. PLoS One 2010; 5: e10458.
25. Marshall SR. Technology insight: ECP for the treatment of GvHD- Can we offer selective immune control without generalized immunosuppression? Nat Clin Pract Oncol 2006; 3: 302.
26. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006; 12: 440.
27. Strauss G, Osen W, Debatin KM. Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs. Clin Exp Immunol2002; 128: 255.
28. Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med 2003; 54: 29.
29. Johansson U, Walther-Jallow L, Smed-Sorensen A, et al. Triggering of dendritic cell responses after exposure to activated, but not resting, apoptotic PBMCs. J Immunol 2007; 179: 1711.
30. + regulatory T cells and down-regulates cardiac allograft rejection. Biochem Biophys Res Com-mun 2010; 395: 540.